News Focus
News Focus
icon url

DewDiligence

02/17/22 12:47 PM

#8 RE: DewDiligence #7

Disclosure: I'm long ENTA.
icon url

DewDiligence

03/10/22 4:57 PM

#9 RE: DewDiligence #7

icon url

DewDiligence

04/04/22 11:29 AM

#11 RE: DewDiligence #7

ALGS selects lead SARS-CoV-2 PI—phase-1 expected to start in early 2023 (or very late 2022):

https://finance.yahoo.com/news/aligos-therapeutics-selects-drug-candidate-120000412.html

The timing of this program was known from the Leerink webcast two months ago (#msg-167924816), so the only new news is that a lead compound has been selected.